Proposal of a new staging and grading system of the liver for primary biliary cirrhosis

被引:41
作者
Hiramatsu, K.
Aoyama, H.
Zen, Y. [1 ]
Aishima, S.
Kitagawa, S.
Nakanuma, Y.
机构
[1] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan
[2] Kanazawa Univ, Grad Sch Med, Dept Internal Med 1, Kanazawa, Ishikawa, Japan
[3] Univ Ryukyus, Dept Internal Med 2, Nishihara, Okinawa 90301, Japan
[4] Kanazawa Univ Hosp, Div Pathol, Kanazawa, Ishikawa, Japan
[5] Fukui Saiseikai Hosp, Dept Pathol, Fukui, Japan
[6] Kyushu Univ, Grad Sch Med, Dept Pathol, Fukuoka, Japan
关键词
cholangitis; cholestasis; grading; overlap syndrome; primary biliary cirrhosis; staging;
D O I
10.1111/j.1365-2559.2006.02537.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To define a new histological staging and grading system for primary biliary cirrhosis (PBC), to provide more information reflecting clinical laboratory data and the prognosis to hepatologists. First, 17 histological lesions of PBC were scored in 188 needle liver biopsy specimens. Factor analysis yielded three independent groups of factors: factor 1 (fibrosis, fibrous piecemeal necrosis, orcein-positive granules, bile plugs, Mallory bodies, feathery degeneration, bile duct loss and atypical ductular proliferation); factor 2 (portal inflammation, eosinophilic infiltration, lymphoid follicles, epithelioid granulomas, interface hepatitis and chronic cholangitis); and factor 3 (interface hepatitis, lobular hepatitis, acidophilic bodies and pigmented macrophages). The eight findings of factor 1, but not factors 2 and 3, were significantly correlated with clinical laboratory data and scores in the Mayo Clinic's prognostic model. Factor 1 lesions may reflect histological progression (staging), while factor 2 and 3 lesions may relate to necroinflammatory activity (grading). Then, we devised a staging and grading system using three lesions (bile duct loss, fibrosis and orcein-positive granules) from factor 1 and three from factors 2 and 3 (chronic cholangitis, interface hepatitis and lobular hepatitis). This new system might provide more pathological information on PBC patients for hepatologists.
引用
收藏
页码:466 / 478
页数:13
相关论文
共 31 条
[1]   CD40 activation-induced, Fas-dependent apoptosis and NF-κB/AP-1 signaling in human intrahepatic biliary epithelial cells [J].
Afford, SC ;
Ahmed-Choudhury, J ;
Randhawa, S ;
Russell, C ;
Youster, J ;
Crosby, HA ;
Eliopoulos, A ;
Hubscher, SG ;
Young, LS ;
Adams, DH .
FASEB JOURNAL, 2001, 15 (13) :2345-2354
[2]   Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis [J].
Angulo, P ;
Batts, KP ;
Therneau, TM ;
Jorgensen, RA ;
Dickson, ER ;
Lindor, KD .
HEPATOLOGY, 1999, 29 (03) :644-647
[3]  
[Anonymous], LIVER BIOPSY INTERPR
[4]  
[Anonymous], 2001, PATHOLOGY LIVER
[5]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[6]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[7]   PROGNOSIS IN PRIMARY BILIARY-CIRRHOSIS - MODEL FOR DECISION-MAKING [J].
DICKSON, ER ;
GRAMBSCH, PM ;
FLEMING, TR ;
FISHER, LD ;
LANGWORTHY, A .
HEPATOLOGY, 1989, 10 (01) :1-7
[8]   Natural history of nonalcoholic steatohepatitis:: A longitudinal study of repeat liver biopsies [J].
Fassio, E ;
Alvarez, E ;
Domínguez, N ;
Landeira, G ;
Longo, C .
HEPATOLOGY, 2004, 40 (04) :820-826
[9]  
Harada K, 1997, HEPATOLOGY, V26, P1399
[10]   THE CANADIAN MULTICENTER DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS [J].
HEATHCOTE, EJ ;
CAUCHDUDEK, K ;
WALKER, V ;
BAILEY, RJ ;
BLENDIS, LM ;
GHENT, CN ;
MICHIELETTI, P ;
MINUK, GY ;
PAPPAS, SC ;
SCULLY, LJ ;
STEINBRECHER, UP ;
SUTHERLAND, LR ;
WILLIAMS, CN ;
WITTSULLIVAN, H ;
WOROBETZ, LJ ;
MILNER, RA ;
WANLESS, IR .
HEPATOLOGY, 1994, 19 (05) :1149-1156